Details for 2017823190

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON ANTI-SCLEROSTIN-ANTIKÖRPERN BEI DER BEHANDLUNG VON OSTEOGENESIS IMPERFECTA

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017823190

EP Publication Number

3478719

E-Number

1356332

Language

PCT Number

GB17053850

Publication Date

08.05.2019 A

20.01.2021 B1

Registration Date

20.01.2021

AT Publication Date

15.02.2021

Application Date

21.12.2017

Registration Number

Priorities

21.12.2016

201662437353 P

IPC

C07K 16/22 20060101AFI20180629BHEP

Maximum Duration of Protection

21.12.2037

Owner

Mereo Biopharma 3 Limited4th Floor 1 Cavendish Place London W1G 0QFGB

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

JUNKER, Uwec/o Roche Innovation Center Grenzacherstrasse 124 Building 68 / Room 217 4070 BaselCH

KNEISSEL, Michaelac/o Novartis Pharma AG Postfach 4002 BaselCH

HALL, Anthony KentPrins Hendriklaan 16 2341 JB OegstgeestNL

EUDY, Rena Joy25 Lawler Road West Hartford Connecticut 06117US

RIGGS, Matthew Manning1189 Saybrook Road Haddam Connecticut 06438US

Information about Fees